Skip to main content
OpenTrials
Completed

NCT Number: NCT02021877

Evidence Based Diagnostics and Treatment Planning Solution for Traumatic Brain Injuries

Adult patients, age ≥ 18 years, with clinically diagnosed mild, moderate or severe brain trauma will be asked to participate in the study. This prospective database will consist of 400 subjects with TBI, 200 from both TUCH and Cambridge Addenbrooke's Hospital. In addition, 100 controls will be recruited, with 50 from both centres.This study is a prospective clinical observational study with detailed data collecting. All patients will be treated according to the accepted, standardized, existing guidelines that are based on national and international recommendations. New treatment interventions will NOT be evaluated during the data acquisition for this study.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Turku University Hospital, Turku, Finland

Loading trial locations.

About this study

Aim in this study is to collect large amounts of data in adult subject population, who have suffered mild, moderate or severe brain trauma. This data will be added up to the existing large TBI databases from IMPACT as well as to the retrospective brain trauma data sets collected at the Turku University Hospital after the year 1995 and to the prospectively collected existing data set from the University of Cambridge.

Data will contain patient characteristics, injury mechanisms, and patients' physiological status and findings immediately after the incident as well as through the processes of diagnostics, emergency treatment and in-hospital care. All data during these phases will follow the recommendations of Common Data Elements (advanced version) in TBI studies by the IMPACT investigators.

Immediate head CT will be performed according to the existing guidelines, and head MRI with modern techniques as soon as the patient's wellbeing will allow the imaging to be done.

During the intensive care unit (ICU) visit a database of EEG signals will be collected and the relevant information components will be extracted to provide inputs for the care decision algorithm. The aim is to investigate the feasibility of continuous EEG monitoring on the detection of epileptic seizures and other adverse events to enable rapid intervention during the patient's ICU stay and to improve outcome prediction.

The investigators will also search new metabolomic, lipidomic, and genetic biomarkers related to TBIs through analyzing blood samples drawn in different time points.

Based on all these factors, simulation models will be brought up as to help clinicians determine the earliest possible prognosis and to decide, whether patient would benefit from a particular care during the acute phase of a TBI.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Severe or moderate brain trauma subjects with need of ICU care:
  • Glasgow Coma Score (GCS) ≤ 8 after the primary stabilization has been performed in the field (= patient not hypoxic or hypotensive) and at least 30 min interval from the moment of injury.
  • GCS 9 - 13 and the patient is deteriorating
  • The patient has GCS ≤ 13 and has other injuries, which require interventions for hemodynamic or ventilatory incidents
  • The patient is in urgent need of neurosurgery (craniotomy, impression skull fracture, severe haemorrhagic contusion, or ICP measurement)

Moderate or mild brain trauma not in need of ICU care:

  • All other patients who fulfil the diagnostic criteria for an acute TBI but without any exclusion criteria defined below

Exclusion criteria

  • Age < 18 years at study entry
  • Blast-induced TBI
  • Perforating or penetrating mechanism of TBI
  • Unable to live independently because of a brain disease (= e.g. people with moderate dementia, Down's syndrome, cerebral palsy etc.) or other medical cause before the injury
  • TBIs or suspected TBIs not needing cranial CT imaging (excludes the mildest TBIs with negligible risk for incomplete recovery)

Inclusion criteria

for control subjects

  • Age ≥ 18 years at study entry
  • Acute orthopaedic non-trivial trauma that needs either surgery or conservative measures and clinical follow-up (including mere superficial soft tissue injuries)

Exclusion criteria

for control subjects

  • Age < 18 years at study entry
  • Loss of consciousness or amnesia or neurological symptoms or signs in conjunction with the injury, or suspicion of such
  • External injuries of the head caused by the acute injury
  • Acute injury of the spinal column and/or cord (including whiplash-injuries of the neck) - superficial soft tissue injuries without neurological symptoms or signs are not an exclusion
  • Any earlier TBI with loss of consciousness, amnesia or prolonged symptoms (days or more)
  • Suspicion or signs of TBI (recent or remote) in brain MRI
  • Trauma that needs care or observation at ICU, at any time point during the acute hospital period
  • Previous neurological illnesses with obvious permanent alteration in CNS function (cerebral palsy, multiple sclerosis, stroke, encephalitis, degenerative CNS disorders, etc.)

Treatment and study plan

Primary outcomes

  1. Glasgow Outcome Scale -extended

    Time frame: Time for outcome assessment is nine months (range 3 to 12 months) from the injury.

    •General outcome is assessed using the Glasgow Outcome Scale, extended version (GOS-E)

Secondary outcomes

  1. QOLIBRI

    Time frame: 3 - 12 months from injury

    •The quality of life is assessed using QOLIBRI

  2. CANTAB

    Time frame: 3 - 12 months from injury

    •Cognitive outcome is assessed using CANTAB, an electronic test battery to evaluate neuropsychological function. The subtests used include tests of visual memory, executive function, working memory, planning, attention, semantic/verbal memory, decision-making, and response control

  3. Rivermead Post Concussion Symptom Questionnaire

    Time frame: 3 - 12 months from injury

    •Subjective outcome is assessed using the Rivermead Post-Concussion Symptom Questionnaire (RPCSQ)

  4. SF-36

    Time frame: 3 - 12 months from injury

    •Subjective outcome is assessed using the SF-36 questionnaire

Sponsors and collaborators

Lead sponsor

Turku University Hospital

Other Gov

Collaborators

  • Cambridge University Hospitals NHS Foundation Trust
  • GE Healthcare
  • Imperial College London
  • Kaunas University of Technology
  • VTT Technical Research Centre of Finland

Registry information

Official study title

Evidence Based Diagnostics and Treatment Planning Solution for Traumatic Brain Injuries - the TBIcare Project

Important dates

Study start
2011
Primary completion
2014
Study completion
2014
First posted
Dec 27, 2013
Registry last updated
May 27, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.